How have BLAC shares performed in 2024?

Bellevue Life Sciences Acquisition's stock was trading at $10.50 on January 1st, 2024. Since then, BLAC shares have increased by 1.8% and is now trading at $10.6850. View the best growth stocks for 2024 here .

Are investors shorting Bellevue Life Sciences Acquisition?

Bellevue Life Sciences Acquisition saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,200 shares, an increase of 46.7% from the March 31st total of 1,500 shares. Based on an average daily volume of 23,800 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the company's stock are short sold. View Bellevue Life Sciences Acquisition's Short Interest .

Who are Bellevue Life Sciences Acquisition's major shareholders?

Bellevue Life Sciences Acquisition's stock is owned by many different institutional and retail investors. Top institutional investors include Wealthspring Capital LLC (0.61%).

How do I buy shares of Bellevue Life Sciences Acquisition?

Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BLAC

Bellevue Life Sciences Acquisition (BLAC) Stock Price, News & Analysis

→ AI finds its first serious application (From Wall Street Star) (Ad)

Free BLAC Stock Alerts

$10.68

0.00 (0.00%)

(As of 04/25/2024 ET)

Compare

Today's Range: $10.69
▼
$10.69
50-Day Range: $10.56
▼
$10.83
52-Week Range: $10.11
▼
$11.16

Volume: 6,121 shs
Average Volume: 37,084 shs
Market Capitalization: $96.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Ownership SEC Filings Short Interest Social Media

Get Bellevue Life Sciences Acquisition alerts:

Ad Insiders Exposed

The Hard Truth About Investing For Retirement

Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.

Click To Access This Powerful Training Right Now!

About Bellevue Life Sciences Acquisition

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

BLAC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BLAC Stock News Headlines

April 16, 2024 | americanbankingnews.com

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Short Interest Up 7.1% in March

April 21, 2023 | wsj.com

Bellevue Life Sciences Acquisition Corp.

April 25, 2024 | Insiders Exposed (Ad)

The Hard Truth About Investing For Retirement

April 18, 2023 | seekingalpha.com

BLACW Bellevue Life Sciences Acquisition Corp. WT EXP 020928

See More Headlines

Receive BLAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/25/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Unclassified
Industry: Holding & other investment offices
Sub-Industry: N/A
Current Symbol: NASDAQ:BLAC
CUSIP: N/A
CIK: 1840425
Web: www.bellevuespac.com
Phone: 425-635-7700
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 9,060,000
Free Float: 7,633,000
Market Cap: $96.81 million
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Kuk Hyoun Hwang (Age 47)
CEO & Director
Mr. David Jin Yoo (Age 50)
Chief Financial Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BLAC Stock Analysis - Frequently Asked Questions

How have BLAC shares performed in 2024?: Bellevue Life Sciences Acquisition's stock was trading at $10.50 on January 1st, 2024. Since then, BLAC shares have increased by 1.8% and is now trading at $10.6850.
View the best growth stocks for 2024 here.
Are investors shorting Bellevue Life Sciences Acquisition?: Bellevue Life Sciences Acquisition saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,200 shares, an increase of 46.7% from the March 31st total of 1,500 shares. Based on an average daily volume of 23,800 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the company's stock are short sold.
View Bellevue Life Sciences Acquisition's Short Interest.
Who are Bellevue Life Sciences Acquisition's major shareholders?: Bellevue Life Sciences Acquisition's stock is owned by many different institutional and retail investors. Top institutional investors include Wealthspring Capital LLC (0.61%).
How do I buy shares of Bellevue Life Sciences Acquisition?: Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BLAC) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial